NRG1 and breast carcinoma: Consistent with active histone marks status, chromatin accessibility of the Nrg1 enhancer (+200 bp) was also increased by HG treatment in breast cancer cells, suggesting that HG resulted in an open chromatin landscape within the Nrg1 enhancer region.